Tuesday, February 27, 2024 |

AstraZeneca announces state-of-the-art facility in Rockville

February 7, 2024

AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, the company announced Tuesday. The facility is part of the launch of its life-saving cell therapy platforms in the United States for critical cancer trials and future commercial supply. It is expected to create more than 150 new highly-skilled jobs to initially focus on manufacturing T-cell therapies to enable clinical trials to be conducted around the world.

Article Source: The Daily Record

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.